Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,504 public trials 545 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NCT06656494

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Yale University, Yale Cancer Center New Haven, Connecticut, United States

NYU Langone Health New York, United States

St Vincent's Hospital Sydney, New South Wales, Australia

Royal Perth Hospital Perth, Western Australia, Australia

View all 22 locations

View Trial Details

Recruiting

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

NCT07565220

Conditions: Acute Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), +19 more
Locations: UMPC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

NCT07771803

Conditions: AML (Acute Myeloid Leukemia), Disease Attributes, Hematologic Diseases, +10 more
Locations: MDA at Cooper University Health Care Camden, New Jersey, United States

View Trial Details

Recruiting

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

NCT07302776

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

NCT02203903

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Childrens National Medical Center Washington D.C., District of Columbia, United States

Tania Jain, MD Baltimore, Maryland, United States

View Trial Details

Recruiting

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

NCT06459024

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +10 more
Locations: University Hospital Aachen Aachen, Germany

University Hospital Greifswald Greifswald, Germany

University Hospital Halle Halle, Germany

University Hospital of Rostock Rostock, Germany

View all 40 locations

View Trial Details

Recruiting

PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS

NCT07761533

Conditions: Acute Myeloid Leukemia (AML), Anemia, Anemia, Refractory, +11 more
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

NCT07570407

Conditions: Acute Myeloid Leukemia, Allogeneic HSCT, Disease Attributes, +13 more
Locations: University Hospital Pilsen Pilsen, Czechia

View Trial Details

Recruiting

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

NCT03737955

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Fred Hutchinson Cancer Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

NCT07469592

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions